# Efficacy of Lactobacillus Rhamnosus LRa05 in Gestational Diabetes

> **NCT06901791** · NA · RECRUITING · sponsor: **Wecare Probiotics Co., Ltd.** · enrollment: 80 (estimated)

## Conditions studied

- GDM

## Interventions

- **DIETARY_SUPPLEMENT:** Conventional treatment and Probiotic

## Key facts

- **NCT ID:** NCT06901791
- **Lead sponsor:** Wecare Probiotics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-10
- **Primary completion:** 2025-07-31
- **Final completion:** 2026-03-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06901791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06901791, "Efficacy of Lactobacillus Rhamnosus LRa05 in Gestational Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06901791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*